Search
scPharmaceuticals Inc
SCPHAdd to Watchlist
5.670USD
0.0000.00%
Close 07/02, 13:00（ET）Quotes delayed by 15 min
302.16MMarket Cap
LossP/E TTM
More Details of scPharmaceuticals Inc Company
scPharmaceuticals Inc. is a pharmaceutical company. The Company is focused on developing and commercializing products to optimize the delivery of infused therapies, advance patient care and reduce healthcare costs. The Company develops, internally and through strategic partnerships, products and solutions that aim to expand and advance the outpatient care of select acute conditions. Its lead product candidate, FUROSCIX, consists of its formulation of furosemide delivered via an on-body infuser. FUROSCIX is a formulation of furosemide contained in a pre-filled, Crystal Zenith cartridge and self- administered subcutaneously via a single-use, disposable and wearable on-body delivery system. The Companay’s pipeline programs include SCP-111 (furosemide injection) 80mg/mL is an investigational pH neutral aqueous furosemide formulation that is being developed for subcutaneous administration outside of the hospital setting, including patient self-administration in the home.
scPharmaceuticals Inc Info
Ticker SymbolSCPH
Company namescPharmaceuticals Inc
IPO dateNov 17, 2017
CEOMr. John H. Tucker
Number of employees162
Security typeOrdinary Share
Fiscal year-endNov 17
Address25 Burlington Mall Road, Suite 203
CityBURLINGTON
Stock exchangeNASDAQ Global Select Consolidated
CountryUnited States of America
Postal code01803
Phone16175170730
Websitehttps://www.scpharmaceuticals.com/
Ticker SymbolSCPH
IPO dateNov 17, 2017
CEOMr. John H. Tucker
Company Executives of scPharmaceuticals Inc
Name
Name/Position
Position
Shareholding
Change
Ms. Katherine Miranda
Ms. Katherine Miranda
Senior Manager - Corporate Communication
Senior Manager - Corporate Communication
--
--
Mr. Michael E. Castagna
Mr. Michael E. Castagna
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--
Mr. Chris Prentiss
Mr. Chris Prentiss
Chief Financial Officer, Director
Chief Financial Officer, Director
--
--
Mr. David Thomson
Mr. David Thomson
Company Secretary, Director
Company Secretary, Director
--
--
Name
Name/Position
Position
Shareholding
Change
Ms. Katherine Miranda
Ms. Katherine Miranda
Senior Manager - Corporate Communication
Senior Manager - Corporate Communication
--
--
Mr. Michael E. Castagna
Mr. Michael E. Castagna
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--
Mr. Chris Prentiss
Mr. Chris Prentiss
Chief Financial Officer, Director
Chief Financial Officer, Director
--
--
Mr. David Thomson
Mr. David Thomson
Company Secretary, Director
Company Secretary, Director
--
--
FAQs
Who are the top five shareholders of scPharmaceuticals Inc?
The top five shareholders of scPharmaceuticals Inc are: Ms. Katherine Miranda
How many institutions hold shares of scPharmaceuticals Inc (SCPH)?
As of 2026Q1, 216 institutions hold shares of scPharmaceuticals Inc, with a combined market value of approximately 2.90M, accounting for 5.40% of the total shares. Compared to 2025Q4, institutional shareholding has increased by -51622125.00.